Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Thermally-Activated Delayed Fluorescence Nanoparticle Assemblies for Photodynamic Therapy

Description du projet

Traitement de précision contre le cancer

La thérapie photodynamique (PDT) est un traitement peu invasif du cancer qui associe la lumière d’un laser à des colorants photosensibilisants pour éliminer les cellules cancéreuses. Les réactions photochimiques entraînent la production d’espèces réactives de l’oxygène qui provoquent l’apoptose des cellules cancéreuses. Malgré ses promesses, la PDT a connu des progrès limités, seuls quelques colorants ayant été approuvés pour un usage clinique. Avec le soutien du programme Actions Marie Skłodowska-Curie, le projet TADF-PDT introduira une nouvelle classe de colorants basés sur la fluorescence retardée activée thermiquement (TADF). Ces matériaux TADF efficaces seront délivrés au moyen de vésicules extracellulaires biocompatibles, offrant ainsi une stratégie de nouvelle génération pour un traitement du cancer plus sûr et plus ciblé.

Objectif

Photodynamic Therapy (PDT) is a non-invasive cancer treatment that uses light-activated, photosensitising dyes to generate highly reactive oxygen species (ROS) within a localised biological environment, leading to the destruction of cancer cells, while sparing surrounding healthy tissue. The PDT process comprises two stages: administration of a dye, followed by irradiation with light. Since ROS is only generated at the light-activated sites, tissue destruction is highly localised and side effects are significantly reduced. The potential for PDT is clear. However, for all this potential, widespread adoption has stagnated: only three dyes have been approved for cancer treatment globally, while the dye most commonly studied in clinical trials - Photofrin - is a statistical mixture of oligomeric porphyrins. Dye design for many years has focussed on porphyrins derived from Photofrin, and more recently phosphorescent ruthenium(II) polypyridyl complexes. However, in this proposal, a new design strategy is proposed: thermally-activated delayed fluorescence (TADF) dyes are the targets of interest. These are all-organic compounds that have small singlet-triplet energy gaps, which causes them to undergo rapid intersystem crossing and reverse intersystem crossing between the singlet and triplet states. By accessing the triplet state, they can readily generate singlet oxygen, which is one form of ROS, marking their potential for PDT. These compounds have been widely used organic device applications, but their uses in biological applications such as imaging and particularly PDT are much less. This proposal addresses this gap, using novel, cationic, near-IR emitting, TADF dyes. Their delivery to cells will be achieved using biocompatible, Extracellular Vesicles (EVs), which have been shown to be improved PDT delivery agents over other methods.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-MSCA-2024-PF-01

Voir tous les projets financés au titre de cet appel

Coordinateur

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Contribution nette de l'UE
€ 260 347,92
Adresse
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Royaume-Uni
Région
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée